Skip to the reference entry
Notice: This is NOT an official government website. We are not affiliated with any government agency.

Reference entry

Ipamorelin

Also listed as Ipamorelin acetate

Read the scope, examine the source, and keep your own question alongside the evidence.

Status labels apply within the product, route, and use described below. Read the limitations alongside that scope.

Scoped product status
Not FDA-approved
Evidence label
Randomized evidence

Status as of

Reference fields

Sources for these fields

Product and use
The reviewed FDA record identifies no approved ipamorelin product.
Route context
The cited trial used intravenous treatment after bowel surgery.
Mechanism
A ghrelin-receptor agonist.
Evidence
A randomized postoperative-ileus trial did not show a significant efficacy advantage.
Limitations
That setting does not establish anti-aging or muscle-building benefit.
Safety
FDA flags safety uncertainties for injectable ipamorelin.

Sources

These references support the fields as a group. Follow a source to check the original wording and its scope.

  1. FDA safetyFDA · Checked
  2. FDA ipamorelinFDA · Checked
  3. BeckPubMed · Checked

Continue reading

Reading topics: Hormones. These organize the library and do not describe recommended uses.

Educational reference information. No clinician review is claimed. This entry does not provide personal medical advice.